Wednesday, July 06, 2022 6:20:07 PM
Roche said on "it would focus on its other COVID-19 products including antibody cocktail Ronapreve, developed in partnership with Regeneron (REGN.O)"
https://www.reuters.cobm/business/healthcare-pharmaceuticals/atea-pharma-says-deal-develop-covid-19-pill-with-roche-terminated-2021-11-16/
https://www.fiercepharma.com/pharma/covid-19-antibody-cocktail-from-regeneron-roche-slashes-hospitalizations-and-tackles
#John Rim #Roche #Reuters #Regn #Samsung
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM